BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2013114)

  • 1. Nigericin enhances mafosfamide cytotoxicity at low extracellular pH.
    Jähde E; Glüsenkamp KH; Rajewsky MF
    Cancer Chemother Pharmacol; 1991; 27(6):440-4. PubMed ID: 2013114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro.
    Jähde E; Glüsenkamp KH; Klünder I; Hülser DF; Tietze LF; Rajewsky MF
    Cancer Res; 1989 Jun; 49(11):2965-72. PubMed ID: 2720657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of intracellular pH is not the mechanism for the synergistic interaction between photodynamic therapy and nigericin.
    Varnes ME; Bayne MT; Bright GR
    Photochem Photobiol; 1996 Nov; 64(5):853-8. PubMed ID: 8931385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased drug cytotoxicity at reduced pH counteracts cyclophosphamide resistance in cultured rat mammary carcinoma cells.
    Jähde E; Glüsenkamp KH; Rajewsky MF
    Int J Cancer; 1989 Dec; 44(6):1082-7. PubMed ID: 2606575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of nigericin and 5-(N-ethyl-N-isopropyl)amiloride: an approach to therapy based on cellular acidification and the inhibition of regulation of intracellular pH.
    Hasuda K; Lee C; Tannock IF
    Oncol Res; 1994; 6(6):259-68. PubMed ID: 7865901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazone.
    Newell KJ; Tannock IF
    Cancer Res; 1989 Aug; 49(16):4477-82. PubMed ID: 2743336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells.
    Laurencot CM; Kennedy KA
    Oncol Res; 1995; 7(7-8):371-9. PubMed ID: 8747600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects.
    Yamagata M; Tannock IF
    Br J Cancer; 1996 Jun; 73(11):1328-34. PubMed ID: 8645575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of cultured malignant cells from mitoxantrone cytotoxicity by low extracellular pH: a possible mechanism for chemoresistance in vivo.
    Jähde E; Glüsenkamp KH; Rajewsky MF
    Eur J Cancer; 1990 Feb; 26(2):101-6. PubMed ID: 2138903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of intracellular pH and thermosensitivity.
    Lyons JC; Kim GE; Song CW
    Radiat Res; 1992 Jan; 129(1):79-87. PubMed ID: 1728060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-dependent effects of the ionophore nigericin on response of mammalian cells to radiation and heat treatment.
    Varnes ME; Glazier KG; Gray C
    Radiat Res; 1989 Feb; 117(2):282-92. PubMed ID: 2922473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of compounds that interfere with the regulation of intracellular pH: a potential new class of anticancer drugs.
    Rotin D; Wan P; Grinstein S; Tannock I
    Cancer Res; 1987 Mar; 47(6):1497-504. PubMed ID: 3815351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours.
    Newell K; Wood P; Stratford I; Tannock I
    Br J Cancer; 1992 Aug; 66(2):311-7. PubMed ID: 1503904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of recovery from potentially lethal radiation damage in A549 cells by the K+/H+ ionophore nigericin.
    Varnes ME; Menegay HJ; McKenna DS
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):281-5. PubMed ID: 1991689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the regulation of intracellular pH: potential of 5-(N,N-hexamethylene) amiloride in tumour-selective therapy.
    Luo J; Tannock IF
    Br J Cancer; 1994 Oct; 70(4):617-24. PubMed ID: 7917906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures.
    Yen WC; Schmittgen T; Au JL
    Pharm Res; 1996 Dec; 13(12):1887-91. PubMed ID: 8987090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid pH in tumors and its potential for therapeutic exploitation.
    Tannock IF; Rotin D
    Cancer Res; 1989 Aug; 49(16):4373-84. PubMed ID: 2545340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell toxicity of oxazaphosphorine metabolites in comparison to their antileukemic activity.
    Brueggemann SK; Schlenke P; Klich S; Deeken M; Peters SO; Wagner T
    Biochem Pharmacol; 2002 Apr; 63(7):1337-41. PubMed ID: 11960610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan.
    Vukovic V; Tannock IF
    Br J Cancer; 1997; 75(8):1167-72. PubMed ID: 9099966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of tumour intracellular pH and enhancement of melphalan cytotoxicity by the ionophore Nigericin.
    Wood PJ; Sansom JM; Newell K; Tannock IF; Stratford IJ
    Int J Cancer; 1995 Jan; 60(2):264-8. PubMed ID: 7829226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.